Gennex Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE509C01026
  • NSEID:
  • BSEID: 531739
INR
12.62
0.12 (0.96%)
BSENSE

Dec 22

BSE+NSE Vol: 2.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Trident Lifeline
BDH Industries
Gennex Lab.
Bafna Pharma.
Sanjiv.Parant.
Brooks Lab.
Zenotech Lab.
Lyka Labs
Valiant Laborato
Zim Laboratories
Infinium Pharma
Why is Gennex Laboratories Ltd ?
1
Negative results in Sep 25
  • INTEREST(9M) At Rs 3.21 cr has Grown at 79.33%
  • PBT LESS OI(Q) At Rs 4.00 cr has Fallen at -34.64%
  • ROCE(HY) Lowest at 8.58%
2
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 6.69% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -26.67% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Gennex Lab. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Gennex Lab.
-26.67%
-0.53
50.58%
Sensex
9.64%
0.83
11.68%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
22.71%
EBIT Growth (5y)
44.14%
EBIT to Interest (avg)
6.23
Debt to EBITDA (avg)
1.54
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
0.87
Tax Ratio
13.96%
Dividend Payout Ratio
0
Pledged Shares
17.43%
Institutional Holding
0.00%
ROCE (avg)
12.56%
ROE (avg)
9.64%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
18
Industry P/E
34
Price to Book Value
1.44
EV to EBIT
19.57
EV to EBITDA
17.58
EV to Capital Employed
1.37
EV to Sales
2.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.98%
ROE (Latest)
7.82%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PAT(Q)

Highest at Rs 5.03 cr.

-14What is not working for the Company
INTEREST(9M)

At Rs 3.21 cr has Grown at 79.33%

PBT LESS OI(Q)

At Rs 4.00 cr has Fallen at -34.64%

ROCE(HY)

Lowest at 8.58%

DEBT-EQUITY RATIO(HY)

Highest at 0.41 times

NON-OPERATING INCOME(Q)

is 33.99 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is working for Gennex Lab.
Profit After Tax (PAT) - Quarterly
Highest at Rs 5.03 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Gennex Lab.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 4.00 cr has Fallen at -34.64%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Interest - Quarterly
At Rs 1.03 cr has Grown at 102,999,900.00%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Non Operating Income - Quarterly
is 33.99 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Debt-Equity Ratio - Half Yearly
Highest at 0.41 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio